📣 ADDS Basel 2025  |  Friday, September 12, 2025

THERAPEUTIC EXPERTISE

Solutions for Oncology Research

Digital health technologies empower the much-needed transformation of oncology drug development, enabling more effective trial designs that focus on the patient. Remote data collection reduces patient burden and improves the speed, cost-effectiveness, and the patient-centric nature of oncology trials, including immunotherapy treatments such as CAR-T cell therapy and trials investigating associated conditions such as cancer pain and cancer cachexia.

Schedule a Meeting Read Case Studies

Immunotherapy-Related Adverse Events

Immunotherapies including CAR-T cell therapy, Bi-specific T-cell engager (BiTE) therapy, and immune checkpoint inhibitors are promising advancements in cancer treatment, but risk of serious adverse events such as cytokine release syndrome (CRS), neurotoxicity, and sepsis lead to prolonged hospital stays that can increase patient burden and trial costs.

Overcome these barriers with our remote patient monitoring platform and AI-powered risk monitoring. Continuous, remote monitoring of patient vital signs can reduce or eliminate prolonged hospitalization to reduce burden and cost while still prioritizing patient safety.

Key Features and Benefits

  • Algorithm-enabled decision support
  • AI-Powered CRS monitoring
  • Integrated remote patient monitoring platform
  • Real-time data access
gfx1@2x

Oncology Digital Endpoint Guide

To learn more about opportunities with digital health technologies in oncology clinical trials, download our full guide.

Download the Guide
13
trials
2,774
participants
24
countries
495
sites

Discuss your trial needs with one of Ametris' digital health technology experts.

 

 

Let's Connect

Do you have an upcoming trial that could benefit from the use of digital measures?
If so, contact us to learn more.